CCTR Endowment Fund Yields Exciting New Research
VCU surgeon Sudha Jayaraman, M.D., and VCU School of Pharmacy assistant professor Dayanjan Wijesinghe, Ph.D., have collaborated on using mass spectrometry to analyze medications that are in trauma patients’ blood. With funding from the CCTR Endowment Fund, and other VCU sources, their objective was to assess the feasibility of using mass spectrometry in a clinical setting. With the help of VCU Innovation Gateway, they have applied for a patent on the application and set up a company to market it, Mass Diagnostix.
The interdisciplinary VCU team hopes the use of mass spectrometry to analyze patients’ medications will become common practice. They predict in a few years, use of the machines will be standard practice for hospital laboratories.
We are excited to have been able to have helped this project along its way.
For more information about this project, please go to VCU News.
About the CCTR Endowment Fund: The VCU Wright Center for Clinical and Translational Research’s Endowment Fund supports meritorious pilot and feasibility research. This mechanism can support research that applies discoveries generated in the laboratory and preclinical studies to the development of clinical trials. It also may fund proposals that seek to understand the biological basis for clinical manifestations. In addition, these funds may be used by faculty with well-established community academic partnerships for community engaged pilot research activities.
The next deadline for applications will be August 1, November 1 and February 1 for individual awards ($50,000) and May 1 for multi-school awards ($130,000)
Categories Clinical Research, Collaboration, Funding, Research